Effectiveness and Safety Profile of Tofacitinib and Baricitinib in Rheumatoid Arthritis Patients: Results from a 24-Month Real-Life Prospective Study in Southern-Italy. Reumatismo 2022, 74 (3). https://doi.org/10.4081/reumatismo.2022.1511.